Cytosorbents Corporation (CTSO): Price and Financial Metrics
CTSO Price/Volume Stats
| Current price | $0.92 | 52-week high | $2.15 |
| Prev. close | $0.89 | 52-week low | $0.70 |
| Day low | $0.89 | Volume | 76,800 |
| Day high | $0.95 | Avg. volume | 124,929 |
| 50-day MA | $1.11 | Dividend yield | N/A |
| 200-day MA | $0.99 | Market Cap | 50.31M |
CTSO Stock Price Chart Interactive Chart >
Cytosorbents Corporation (CTSO) Company Bio
CytoSorbents Corporation, a critical care focused immunotherapy company, engages in the research, development, and commercialization of medical devices with its platform blood purification technology incorporating a proprietary adsorbent polymer technology. The company was founded in 1997 and is based in Monmouth Junction, New Jersey.
CTSO Price Returns
| 1-mo | -12.38% |
| 3-mo | -14.81% |
| 6-mo | N/A |
| 1-year | -26.69% |
| 3-year | -81.67% |
| 5-year | -77.17% |
| YTD | -17.12% |
| 2023 | -28.39% |
| 2022 | -63.01% |
| 2021 | -47.43% |
| 2020 | 107.01% |
| 2019 | -52.35% |
Continue Researching CTSO
Want to see what other sources are saying about Cytosorbents Corp's financials and stock price? Try the links below:Cytosorbents Corp (CTSO) Stock Price | Nasdaq
Cytosorbents Corp (CTSO) Stock Quote, History and News - Yahoo Finance
Cytosorbents Corp (CTSO) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...